Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Median Technologies secures funding for AI lung cancer diagnostic eyonis™ regulatory filings and commercialization

Jan 24, 2025•over 1 year ago

Contract Type

partnership

Provence-Alpes-Côte d'AzurBiotechnologyHealth CareMedicalMedical Device

Description

Median Technologies announces an agreement with the European Investment Bank (EIB) for a new loan facility of up to €37.5 million and signed an equity line for up to €10 million with IRIS Capital Investment (IRIS). The funds will be used to support eyonis™ Lung Cancer Screening (LCS) Software as a Medical Device (SaMD) FDA regulatory approval and CE mark, as well as to complete ongoing active commercialization partnership discussions with leading U.S. providers of AI diagnostics in the United States.

Company Information

Company

Median Technologies

Location

Provence-Alpes-Côte d'Azur, France

About

Median Technologies is a company that develops eyonis™, a suite of AI-based medical device software for early cancer diagnosis. They are a major global provider of medical image analysis and oncology imaging services for the pharmaceutical industry. The company focuses on enhancing diagnostic accuracy and efficiency in early lung cancer detection. They are committed to facilitating improved screening programs worldwide to save lives.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Median Technologies's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.